REQUEST A DEMO
Total
USD $0.00
Search more companies

Langkawi Pharmacy Sdn. Bhd. (Malaysia)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Langkawi Pharmacy Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Langkawi Pharmacy Sdn. Bhd. is an enterprise in Malaysia, with the main office in Langkawi. The enterprise currently operates in the Biological Product (except Diagnostic) Manufacturing sector. It was first established on April 09, 2019. From the latest financial highlights, Langkawi Pharmacy Sdn. Bhd. reported a net sales revenue drop of 2.76% in 2023. There was a total growth of 5.23% in Langkawi Pharmacy Sdn. Bhd.’s total assets over the same period. In 2023, Langkawi Pharmacy Sdn. Bhd.’s net profit margin decreased by 2.67%.

Headquarters
43 & 45, Jalan Pandak Mayah 5
Langkawi; Kedah; Postal Code: 07000

Contact Details: Purchase the Langkawi Pharmacy Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Langkawi Pharmacy Sdn. Bhd. report to view the information.
Incorporation Date:
April 09, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Langkawi Pharmacy Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.76%
Total operating revenue
-2.76%
Operating profit (EBIT)
-34.27%
EBITDA
-30.2%
Net Profit (Loss) for the Period
-35.09%
Total assets
5.23%
Total equity
-34.25%
Operating Profit Margin (ROS)
-3.48%
Net Profit Margin
-2.67%
Return on Equity (ROE)
-1.21%
Debt to Equity Ratio
13.55%
Quick Ratio
-0.25%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?